Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DARLING INGREDIENTS INC.DAR · Entity 3512 | Director | May 11, 2021 | May 13, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DARLING INGREDIENTS INC.
Report date May 11, 2021 · Filed May 13, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,273 |
Reported balance
After 2021-05-11 transaction · row 1
1 source rowRow 1 · 2021-05-11 · Grant · Acquired 1,908 · Balance 15,273 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MONSANTO CO /NEW/
Report date June 07, 2018 · Filed June 07, 2018
Section 16 reporting ended · disclosed 2018-06-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2018-06-07 · Disposition to issuer · Disposed 6,149 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2018-06-07 · Disposition to issuer · Disposed 26,728 · Balance 0 F4: Represents restricted stock units. F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2018-06-07 · Disposition to issuer · Disposed 8,374 · Balance 0 F5: Represents performance-based restricted stock units. F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 0 |
Reported balance
After 2018-06-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-06-07 · Disposition to issuer · Disposed 8,135 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $89.45 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-06-07 · Disposition to issuer · Disposed 8,390 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $70.69 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-06-07 · Disposition to issuer · Disposed 11,040 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $74.79 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-06-07 · Disposition to issuer · Disposed 12,540 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $90.48 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-06-07 · Disposition to issuer · Disposed 9,120 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $106.05 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-06-07 · Disposition to issuer · Disposed 7,780 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $112.82 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-06-07 · Disposition to issuer · Disposed 7,980 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.34 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-06-07 · Disposition to issuer · Disposed 9,860 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Phantom Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-06-07 · Disposition to issuer · Disposed 2,115 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").
F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.
F4: Represents restricted stock units.
F5: Represents performance-based restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2021 Filed May 13, 2021 20:45 UTC | DARLING INGREDIENTS INC. DAR · Entity 3512 | GrantCommon Stock | 1,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-009893 · doc1.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,273 Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:27 UTC | DARLING INGREDIENTS INC. DAR · Entity 3512 | GrantCommon Stock | 5,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-009134 · doc1.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,365 Read SEC document |
| May 07, 2019 Filed May 8, 2019 20:46 UTC | DARLING INGREDIENTS INC. DAR · Entity 3512 | GrantCommon Stock | 5,299 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-010159 · doc1.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,002 Read SEC document |
| November 05, 2018 Filed Nov 6, 2018 23:12 UTC | DARLING INGREDIENTS INC. DAR · Entity 3512 | GrantCommon Stock | 2,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-005188 · doc1.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,703 Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerPhantom Share Units · Derivative | 2,115 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · derivative · entry 12 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,115 shares Expires not disclosed F1 · derivative.exercise_price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.exercise_price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · derivative.exercise_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.exercise_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. F1 · derivative.expiration_date: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · derivative.expiration_date: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerStock Option (Right to Buy) · Derivative | 9,860 | Not disclosed Strike: $91.34 | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · derivative · entry 11 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,860 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerStock Option (Right to Buy) · Derivative | 7,980 | Not disclosed Strike: $112.82 | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · derivative · entry 10 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,980 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerStock Option (Right to Buy) · Derivative | 7,780 | Not disclosed Strike: $106.05 | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · derivative · entry 9 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,780 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerStock Option (Right to Buy) · Derivative | 9,120 | Not disclosed Strike: $90.48 | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · derivative · entry 8 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,120 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerStock Option (Right to Buy) · Derivative | 12,540 | Not disclosed Strike: $74.79 | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · derivative · entry 7 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,540 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerStock Option (Right to Buy) · Derivative | 11,040 | Not disclosed Strike: $70.69 | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · derivative · entry 6 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,040 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerStock Option (Right to Buy) · Derivative | 8,390 | Not disclosed Strike: $89.45 | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · derivative · entry 5 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,390 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerCommon Stock | 8,374 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · nonDerivative · entry 4 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · shares: Represents performance-based restricted stock units. F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerCommon Stock | 26,728 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · nonDerivative · entry 3 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · shares: Represents restricted stock units. F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerCommon Stock | 8,135 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · nonDerivative · entry 2 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:08 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerCommon Stock | 6,149 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015514 · doc4.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 16:43 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Tax withholdingCommon Stock | 304 | $117.26 | $35,647.04 |
DisclosureSEC source: 0001110783-17-000276 · edgar.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,877 F1 · shares: On November 15, 2017, 979 time-based restricted stock units became fully vested for which taxes became due and payable. 304 restricted stock units were used for the payment of these taxes. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:20 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 2,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000218 · edgar.xml · nonDerivative · entry 2 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,652 F2 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting one-third on November 15, 2018, one-third on November 15, 2019 and the remaining one-third on November 15, 2020. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:20 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 2,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000218 · edgar.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,181 F1 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting on November 15, 2017. Read SEC document |
| October 26, 2017 Filed Nov 16, 2017 16:42 UTC Amendment | MONSANTO CO /NEW/ MON · Entity 165931 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000275 · edgar.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,181 F1 · balance_after: On October 30, 2017, the Company mistakenly filed a Form 4 on the reporting person's behalf reporting the grant of 2,471 restricted stock units vesting on November 15, 2017 as an acquisition of common stock that did not occur. This amended Form 4 is being filed to reflect the deletion of such transaction. The remaining transaction(s) contained in such Form 4 are not amended hereby. Read SEC document |
| October 16, 2017 Filed Oct 18, 2017 16:17 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionOption (Right to Buy) · Derivative | 7,890 | $0.00 Strike: $87.14 | $0.00 |
DisclosureSEC source: 0001110783-17-000181 · edgar.xml · derivative · entry 4 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,890 shares Expires 2017-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the options became exercisable on November 15, 2008, one-third of the options became exercisable on November 15, 2009 and the remainder of the options became exercisable on November 15, 2010, subject to the terms and conditions of the Monsanto Company Long Term Incentive Plan. Read SEC document |
| October 16, 2017 Filed Oct 18, 2017 16:17 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | SaleCommon Stock | 7,890 | $122.25 | $964,552.50 |
DisclosureSEC source: 0001110783-17-000181 · edgar.xml · nonDerivative · entry 2 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,710 F1 · kind: The sale and stock option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 12, 2016. Read SEC document |
| October 16, 2017 Filed Oct 18, 2017 16:17 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionCommon Stock | 7,890 | $87.14 | $687,534.60 |
DisclosureSEC source: 0001110783-17-000181 · edgar.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale and stock option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 12, 2016. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 16:25 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Tax withholdingCommon Stock | 582 | $99.09 | $57,670.38 |
DisclosureSEC source: 0001110783-16-000602 · edgar.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,710 F1 · shares: On November 15, 2016, 1,743 performance-based restricted stock units became fully vested for which taxes became due and payable. 582 restricted stock units were used for the payment of these taxes. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 17:29 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 2,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-16-000546 · edgar.xml · nonDerivative · entry 2 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,292 F2 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting one-third on November 15, 2017, one-third on November 15, 2018 and the remaining one-third on November 15, 2019. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 17:29 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 1,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-16-000546 · edgar.xml · nonDerivative · entry 1 Ringenberg Nicole M · CIK 0001387225 · VP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,355 F1 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting on November 15, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.